SpineMark Corporation

SpineMark Corporation, founded in 2004 and headquartered in San Diego, US, focuses on innovative spinal treatment solutions.SpineMark Corporation is a leader in the development of integrated healthcare delivery systems specifically tailored for operative and non-operative spinal treatments. The company's core offerings include the establishment of Spine Destination Centers, which serve as specialized facilities for spinal care, and Clinical Research Organization services that support groundbreaking clinical trials. These services are designed to enhance treatment options for patients suffering from spinal conditions, thereby addressing the critical need for effective management of such ailments. SpineMark collaborates closely with medical professionals, FDA sponsors, and healthcare providers to ensure that its offerings meet the highest standards of care and innovation.SpineMark Corporation generates revenue through multiple streams, including service contracts with healthcare providers and partnerships with clinical trial sponsors. The transaction structure typically involves B2B engagements, whereby healthcare institutions pay for access to SpineMark's destination centers and clinical research capabilities. Pricing plans may be established based on the scope of services provided, with specific agreements tailored to the individual needs of partner organizations. Flagship offerings, such as the Spine Centers of Excellence, are integral to the company's revenue model, positioning SpineMark as a pivotal player in the spinal health market. The company is focused on launching innovative spinal treatment technologies by late 2023 and expanding its operations into emerging markets across North America and Europe before the end of 2024. This expansion is aimed at increasing accessibility to its specialized services and further improving patient outcomes in spinal health.

1. Series A

   Dec 13, 2005

   Amount

   $10M

   Investors

   Locked